In this video interview, Prof. Damien Gruson, head of the department of clinical biochemistry, Cliniques Universitaires Saint-Luc, describes how point-of-care immunoassays for high-sensitivity cardiac troponin will be a game changer for rapid and accurate diagnosis of myocardial infarction in the emergency department. Gruson details key considerations for healthcare providers looking to transition to this type of immunoassay.